Rapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaks.
INTRODUCTION: Cholera toxin B subunit (CTB) is a component of an internationally licensed oral cholera vaccine. The protein induces neutralizing antibodies against the holotoxin, the virulence factor responsible for severe diarrhea. A field clinical trial has suggested that the addition of CTB to ki...
Main Authors: | Krystal Teasley Hamorsky, J Calvin Kouokam, Lauren J Bennett, Keegan J Baldauf, Hiroyuki Kajiura, Kazuhito Fujiyama, Nobuyuki Matoba |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC3591335?pdf=render |
Similar Items
-
Cholera Toxin B: One Subunit with Many Pharmaceutical Applications
by: Keegan J. Baldauf, et al.
Published: (2015-03-01) -
Spray-Dried Formulation of Epicertin, a Recombinant Cholera Toxin B Subunit Variant That Induces Mucosal Healing
by: Micaela A. Reeves, et al.
Published: (2021-04-01) -
N-Glycosylation of cholera toxin B subunit: serendipity for novel plant-made vaccines?
by: Nobuyuki eMatoba
Published: (2015-12-01) -
Therapeutic Potential of Cholera Toxin B Subunit for the Treatment of Inflammatory Diseases of the Mucosa
by: Joshua M. Royal, et al.
Published: (2017-11-01) -
Hydroponic Treatment of Nicotiana benthamiana with Kifunensine Modifies the N-glycans of Recombinant Glycoprotein Antigens to Predominantly Man9 High-Mannose Type upon Transient Overexpression
by: Sugata Roychowdhury, et al.
Published: (2018-01-01)